EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2

Dimitra Manou, Maria-Angeliki Golfinopoulou, Sara Naif D Alharbi, Hind A Alghamdi, Fatimah Mohammed Alzahrani iD, Achilleas D Theocharis iD

Biomolecules · 2024

DOI: 10.3390/biom14040461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Dimitra Manou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras,…. Hauptthemen laut MEDLINE: Glioblastoma, Receptors, Interleukin-8B, Signal Transduction, Proteoglycans. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serglycin (SRGN) is a pro-tumorigenic proteoglycan expressed and secreted by various aggressive tumors including glioblastoma (GBM). In our study, we investigated the interplay and biological outcomes of SRGN with TGFβRI, CXCR-2 and inflammatory mediators in GBM cells and fibroblasts. SRGN overexpression is associated with poor survival in GBM patients. High SRGN levels also exhibit a positive correlation with increased levels of various inflammatory mediators including members of TGFβ signaling pathway, cytokines and receptors including CXCR-2 and proteolytic enzymes in GBM patients. SRGN-suppressed GBM cells show decreased expressions of TGFβRI associated with lower responsiveness to the manipulation of TGFβ/TGFβRI pathway and the regulation of pro-tumorigenic properties. Active TGFβRI signaling in control GBM cells promotes their proliferation, invasion, proteolytic and inflammatory potential. Fibroblasts cultured with culture media derived by control SRGN-expressing GBM cells exhibit increased proliferation, migration and overexpression of cytokines and proteolytic enzymes including CXCL-1, IL-8, IL-6, IL-1β, CCL-20, CCL-2, and MMP-9. Culture media derived by SRGN-suppressed GBM cells fail to induce the above properties to fibroblasts. Importantly, the activation of fibroblasts by GBM cells not only relies on the expression of SRGN in GBM cells but also on active CXCR-2 signaling both in GBM cells and fibroblasts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaReceptors, Interleukin-8BSignal TransductionProteoglycansFibroblastsVesicular Transport ProteinsHumansCell Line, TumorCell ProliferationParacrine CommunicationReceptor, Transforming Growth Factor-beta Type IBrain NeoplasmsGene Expression Regulation, NeoplasticStromal CellsCarcinogenesis

Stichwörter der Autor:innen

extracellular matrixglioblastomaproteoglycansserglycintumor microenvironment

Substanzen

Receptors, Interleukin-8BserglycinProteoglycansCXCR2 protein, humanVesicular Transport ProteinsReceptor, Transforming Growth Factor-beta Type I

Autor:innen und Institutionen

  • Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece.
  • Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.

ORCID-Profile: Fatimah Mohammed Alzahrani, Achilleas D Theocharis

Förderung

  • Princess Nourah bint Abdulrahman University

Zitieren

APA

Manou, D., Golfinopoulou, M. A., Alharbi, S. N. D., Alghamdi, H. A., Alzahrani, F. M., & Theocharis, A. D. (2024). The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2. Biomolecules. https://doi.org/10.3390/biom14040461

Vancouver

Manou D, Golfinopoulou MA, Alharbi SND, Alghamdi HA, Alzahrani FM, Theocharis AD. The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2. Biomolecules. 2024. doi:10.3390/biom14040461

BibTeX
@article{Manou2024,
  author = {Manou, Dimitra and Golfinopoulou, Maria-Angeliki and Alharbi, Sara Naif D and Alghamdi, Hind A and Alzahrani, Fatimah Mohammed and Theocharis, Achilleas D},
  title = {The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14040461}
}
Kostenlos starten →